Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 55 and up

Cocoa with exercise to boost walking and strength in older adults

Official title: Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial

Run by University of Alabama at Birmingham · NCT07161726 · Data updated 2026-11-12

This study will test whether taking a cocoa supplement high in (-)-epicatechin together with regular aerobic and resistance exercise helps older adults with slow walking speed improve walking and muscle strength more than exercise alone.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages55 Years and up
SexAll
Enrollment36 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedApril 21, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 8, 2026
Trial IDNCT07161726 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 55 years or older with slow walking speed (<1.0 m/s) who can participate in supervised aerobic and resistance training and agree to randomization and study procedures.

Probably not a fit

People already taking flavanol or cocoa supplements, currently enrolled in supervised exercise programs, or with medical contraindications to exercise (for example severe cardiac disease) are unlikely to be eligible or to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized Phase 1/2 study enrolls adults aged 55 and older with slow walking speed (<1.0 m/s) and compares structured aerobic plus resistance training combined with an (-)-epicatechin–rich cocoa supplement versus the same exercise program with a placebo. Participants follow supervised exercise sessions and undergo functional testing of walking performance and muscle strength, with optional muscle biopsy for mechanistic studies. The trial targets mitochondrial function and reactive oxygen species pathways as potential biological reasons some people do not fully respond to exercise alone. The study is single-site at the University of Alabama at Birmingham.

Why it matters

Potential benefit: If successful, adding an (-)-epicatechin–rich cocoa supplement to exercise could produce greater improvements in walking speed and muscle strength than exercise by itself.

How similar studies have gone: Animal studies and small human studies have shown (-)-epicatechin–rich cocoa can improve mitochondrial function, walking performance, and strength, and combining it with exercise helped mice, but larger randomized trials in older adults remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 55 years and older
* Slow walking speed of \< 1m/s
* Willingness to be randomized to either treatment group
* Willingness to participate in all study procedures (muscle biopsy will be optional)

Exclusion Criteria:

* Failure to provide informed consent;
* Regular consumption of flavanol and/or cocoa supplements
* Current involvement in supervised rehabilitation/exercise training program
* Absolute contraindication(s) to exercise training according to American College of Sports Medicine guidelines \[17\]
* Daytime average of systolic blood pressure ≥ 180/100mm Hg.
* Refusal to stop blood thinners such as baby aspirin dose.
* Peripheral vascular disease; peripheral neuropathy; retinopathy
* Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina;
* Myocardial infarction or stroke within past year
* Significant cognitive impairment, including known dementia diagnosis or a Mini-Mental State Examination exam score \< 24
* Progressive, degenerative neurologic disease, e.g., Parkinson's Disease, multiple sclerosis;
* Severe rheumatologic or orthopedic diseases, e.g., awaiting joint replacement, active inflammatory disease;
* Severe pulmonary disease, requiring either steroid pills or injections or the use of supplemental oxygen;
* Hip fracture, hip or knee replacement, or spinal surgery within past 4 months;
* Other significant co-morbid conditions that would impair ability to participate in the exercise-based intervention
* Simultaneous participation in another interventional trial

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Robert T Mankowski, PhD — University of Alabama at Birmingham
  • Study coordinator: Robert T Mankowski, PhD
  • Email: rmankowski@uabmc.edu
  • Phone: 205-996-3006

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.